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IL-27 Suppresses Antimicrobial Activity in Human
Leprosy
Rosane M.B. Teles1,5, Kindra M. Kelly-Scumpia1,5, Euzenir N. Sarno2, Thomas H. Rea3, Maria T. Ochoa3,
Genhong Cheng4 and Robert L. Modlin1,4
The mechanisms by which intracellular pathogens trigger immunosuppressive pathways are critical for
understanding the pathogenesis of microbial infection. One pathway that inhibits host defense responses
involves the induction of type I interferons and subsequently IL-10, yet the mechanism by which type I IFN
induces IL-10 remains unclear. Our studies of gene expression proﬁles derived from leprosy skin lesions
suggested a link between IL-27 and the IFN-β induced IL-10 pathway. Here, we demonstrate that the IL-27p28
subunit is upregulated following treatment of monocytes with IFN-β and Mycobacterium leprae, the intracellular
bacterium that causes leprosy. The ability of IFN-β and M. leprae to induce IL-10 was diminished by IL-27
knockdown. Additionally, treatment of monocytes with recombinant IL-27 was sufﬁcient to induce the
production of IL-10. Functionally, IL-27 inhibited the ability of IFN-γ to trigger antimicrobial activity against
M. leprae in infected monocytes. At the site of disease, IL-27 was more strongly expressed in skin lesions of
patients with progressive lepromatous leprosy, correlating and colocalizing with IFN-β and IL-10 in macrophages.
Together, these data provide evidence that in the human cutaneous immune responses to microbial infection,
IL-27 contributes to the suppression of host antimicrobial responses.
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INTRODUCTION
The ability of microbial pathogens to trigger immune res-
ponses that counteract host defense is critical for the patho-
genesis of infectious disease. Among such pathways, the
induction of IL-10 represents a key mechanism by which
microbes suppress host antimicrobial responses. In some
circumstances, the induction of type I IFNs by the pathogen
represents one trigger for IL-10 production, resulting in a
profound inhibitory effect on innate and adaptive immunity.
As such, the induction of the type I IFN to IL-10 pathway
contributes to chronic progressive disease in bacterial (Teles
et al., 2013) and viral (Teijaro et al., 2013; Wilson et al., 2013)
infections. Therefore, elucidation of the mechanism(s) by
which IL-10 is induced in human immune responses is central
for understanding how microbial pathogens suppress anti-
microbial defense strategies.
Leprosy, a human infectious disease of skin caused by the
intracellular bacterium Mycobacterium leprae, presents as a
spectrum in which the clinical manifestations correlate with
the immune response to the pathogen. As such, leprosy is a
valuable model for investigating human immune responses to
infection. In the skin lesions of leprosy patients, an inverse
correlation exists between the expression of IFN-β and IFN-γ,
as well as their respective downstream gene programs
(Teles et al., 2013). The skin lesions from patients with the
progressive, L-lep form of leprosy display an IFN-β gene
signature, whereas lesions from patients with the localized,
T-lep form of leprosy are characterized by a low IFN-β and
high IFN-γ gene signature. Similarly, IFN-β and IL-10
expression in lesions was signiﬁcantly correlated, which led
to the observation that M. leprae induction of IL-10 was type I
IFN dependent. Both IFN-β and IL-10 inhibit the antimicrobial
effect of IFN-γ on intracellularM. leprae, identifying the IFN-β
and IL-10 axis as a key immunosuppressive pathway in
human mycobacterial infection.
The ability of IFN-β to induce IL-10 is relevant to the
pathogenesis of other microbial infections. For example,
overlap of the IFN-β gene signature in leprosy lesions with the
IFN-β signatures from peripheral blood cells in tuberculosis
patients (Berry et al., 2010; Maertzdorf et al., 2012) identiﬁed
a common signature of 16 IFN-β-induced genes (Teles et al.,
2013). One of these IFN-β downstream genes, IL-27, has
been shown to induce IL-10, leading to the suppression of
lymphocyte responses (Murugaiyan et al., 2009; Liu et al.,
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2013). IL-27 functions as a heterodimer composed of
two subunits: p28 and EBV-induced gene 3 (EBI3), of which
the transcriptional regulation of IL-27p28 has been
studied in cells of the monocyte/macrophage lineage
(Liu et al., 2007). The IL-27 heterodimer activates via an
IL-27 R complex consisting of the unique subunit IL-27 R
(also referred to a TCCR and WSX-1) and the gp130 chain
of IL-6 R. Here, we investigated the role of IL-27 in sup-
pressing human host defense responses against a cutaneous
pathogen.
RESULTS
IFN-β induces IL-27 in human monocytes
To begin evaluating the role of IL-27 in the IFN-β downstream
network, we ﬁrst examined whether IFN-β induces IL-27
expression in adherent monocytes using an ELISA that
measures the levels of the IL-27 heterodimer. Indeed, IFN-β
signiﬁcantly induced IL-27 in human monocytes (Figure 1a).
Both IFN-β and IL-27 induced IL-10, with the induction of
IL-10 by IFN-β and IL-27 highly correlated in monocytes from
the same donors (Figure 1b). These data suggested the
possibility that IFN-β induction of IL-10 in human monocytes
was IL-27 dependent.
IL-27 participates in IFN-β-induced IL-10 production
In order for us to determine whether IFN-β induction of IL-10
was IL-27 dependent, we knocked down IL-27 expression
using siRNAs (to our knowledge there is no blocking
monoclonal antibody to IL-27). Human peripheral blood
mononuclear cells were transfected with a pool of siRNAs
speciﬁc for the p28 subunit of IL-27 (siIL27) or a pool of non-
speciﬁc siRNAs (siCtrl), for 24 hours, then stimulated with
IFN-β for 3 or 24 hours. Transfection of siIL27 inhibited
IL-27p28 mRNA expression at 3 hours by470% as compared
with siCtrl, in both the media and IFN-β-stimulated cultures
(Figure 1c). Both IL-10 mRNA (P= 0.02, Figure 1d) measured
at 3 hours and protein (P= 0.006, Figure 1e) measured by
ELISA at 24 hours were signiﬁcantly inhibited by the knock-
down of IL-27p28 compared with siCtrl cultures.
LiveM. leprae induces the production of IFN-β, IL-27, and IL-10
in human monocytes
Previously, we found that M. leprae induces IFN-β expression
by monocytes (Teles et al., 2013). Here, we investigated a
dose titration for the induction of IFN-β, IL-27, and IL-10 by
M. leprae (Figure 2a). Increasing the M. leprae multiplicity of
infection (MOI) resulted in enhanced IL-27 production in
monocytes which plateaued at an MOI of 10. Similarly, IFN-β
and IL-10 release plateaued at an MOI of 10, such that this
was the dose used for further experiments. We further
demonstrate that M. leprae–induced IFN-β and IL-10 produc-
tion in the same donors correlated signiﬁcantly (Figure 2b). In
addition, M. leprae–induced IL-27 heterodimer and IL-10
produced in the same donors signiﬁcantly correlated
(Figure 2c). Knockdown of IL-27p28 mRNA signiﬁcantly
inhibited M. leprae–induced IL-10 mRNA expression by
480% compared with siCtrl (P=0.03, Figure 2d and e).
Together, these experiments demonstrate a role for IL-27 in
both IFN-β and M. leprae induction of IL-10.
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Figure 1. Correlation of IL-10 production by IFN-β and IL-27. Monocytes stimulated for 3 or 24 hours with IFN-β (273 Uml− 1) and IL-27 (40 ngml−1).
(a) Production of IL-27 in response to stimulation with IFN-β (n= 6). (b) Correlation of IL-10 produced in response to IFN-β (x axis) and IL-27 (y axis). (c)
Knockdown of IL-27 (ON-TARGET plus; siIL27-black bars) or non-targeting siRNA (siCtrl-white bars). Quantitative PCR (qPCR) results displaying arbitrary
unit (AU) 3 hours following stimulation. IL-27p28 is signiﬁcantly reduced in siIL27 samples compared with siCtrl (n=11, P= 0.03). (d) qPCR showing relative
fold change of IL-10 production using ΔΔCT method 3 hours after stimulation with IFN-β (n=11, P= 0.02). Levels were normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and compared with unstimulated cells (media) from siCtrl (n= 3, P= 0.006). (e) IL-10 protein 24 hours following stimulation
with IFN-β (n=3). Statistical signiﬁcance was calculated by Student’s t-test; *P⩽ 0.05 comparing siCtrl with siIL27.
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IL-27 mRNA and protein are differentially expressed in L-lep
lesions and correlate with IFN-β and IL-10 expression in leprosy
skin lesions
The inverse correlation of IFN-β versus IFN-γ induced gene
expression signatures in leprosy lesions led us to hypothesize
that IL-27 contributes to the local immune response in
leprosy. In addition to the T-lep and L-lep forms of leprosy,
we examined reversal reactions (RRs), representing a shift
from the L-lep to T-lep part of the disease spectrum,
accompanied by a reduction in bacilli in lesions and
enhanced Th1 cytokine responses (Yamamura et al., 1992).
IL-27p28, but not IL-27 EBI3 mRNAs, was found to be
differentially expressed in L-lep compared with T-lep lesions
(Figure 3a and b). RR lesions expressed IL-27p28 mRNA at
levels similar to T-lep lesions, and greater than in L-lep
lesions. However, IL-27 EBI3 mRNA expression was greater in
RR lesions compared with both L-lep and T-lep lesions,
though this increase was not signiﬁcant (Figure 3b). The
expression levels of IL-27p28, but not IL-27 EBI3, directly
correlated with IL-10 in the microarray data (r= 0.71 and
r= 0.00959, respectively, Figure 3c and d). The elevated
expression of IL-27p28 transcripts in L-lep versus T-lep and
RR lesions and correlation with IL-10 mRNA expression was
corroborated by PCR of an independent set of skin biopsy
specimens (Figure 3e and f).
The distribution and localization of IL-27 protein in leprosy
lesions was examined by immunohistochemistry and
confocal laser microscopy using a mAb that recognized the
IL-27 heterodimer. Similar to IL-27p28 mRNA, IL-27 protein
was also more highly expressed in L-lep lesions compared
with T-lep and RR lesions (Figure 4a). In addition, IL-27
protein colocalized with CD209+ and CD163+ macrophages,
of relevance since these markers identify the predominant
macrophage phenotype in L-lep lesions and is reproduced
in vitro by the differentiation of monocytes by IL-10
(Figure 4b) (Montoya et al., 2009). In addition, some IL-27
was detected in CD3+ T cells (Figure 4b). Triple immuno-
ﬂuorescence revealed that IFN-β, IL-27, and IL-10 are co-
expressed at the cellular level in L-lep lesions, with some cells
also expressing individual cytokines, indicating autocrine and
paracrine production of the three cytokines (Figure 4c). Taken
together, the immunohistology data indicate that IL-27, along
with IFN-β and IL-10, are most strongly expressed in L-lep
lesions, therefore associated with the progressive form of
leprosy.
IL-27 prevents IFN-γ-dependent antimicrobial activity against
M. leprae in human monocytes
Next, the effect of IL-27 on IFN-γ induced antimicrobial
activity against M. leprae was evaluated. Human adherent
monocytes were pretreated with IFN-γ, and then infected with
M. leprae at an MOI of 10:1 overnight resulting in infection of
approximately 80% of the monocytes infected with about two
bacteria per cell. After the overnight infection, monocytes
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Figure 2. Correlation of IL-10 and IL-27 production byM. leprae.Monocytes were stimulated for 24 hours with mLEP (M. leprae) (multiplicity of infection (MOI)
1:1, 5:1, 10:1, 20:1) to detect IFN-β, IL-27, and IL-10 levels. (a) Production of IFN- β, IL-27, and IL-10 in response to stimulation with mLEP (n= 4, *Po0.05).
(b) Correlation of IL-10 (x axis) and IL-27 (y axis) produced in response to mLEP. (c) Correlation of IL-10 (x axis) and IFN-β (y axis) produced in response to mLEP.
(d) Quantitative PCR (qPCR) results displaying arbitrary unit (AU) of IL-27p28 transcripts 3 hours following stimulation. IL-27 is reduced in siIL27 (black bars)
samples compared with siCtrl (white bars; n=4, P= 0.03). (e) qPCR showing relative fold change of IL-10 production using ΔΔCT method 3 hours after
stimulation with mLEP. Levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and compared with unstimulated cells (media) from
siCtrl. (n= 4, P=0.02). Signiﬁcance was calculated by Student’s t-test; *P⩽ 0.05 comparing siCtrl with siIL27.
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were treated with IFN-γ, IFN-β+IFN-γ, IL-27+IFN-γ, or IL-10
+IFN-γ and M. leprae viability measured after 5 days. IFN-γ
induced an antimicrobial activity againstM. leprae in infected
monocytes, reducing the number of viable bacilli by
approximately 60% (Figure 5). Similar to IFN-β and IL-10,
the addition of IL-27 abrogated the IFN-γ-induced antimicro-
bial response (Figure 5). Because the experiments are
performed over a 5-day period, we could not assess whether
IFN-β inhibition of IFN-γ-induced antimicrobial activity was
IL-27 dependent, as knockdown of IL-27 using siRNA is
transient. In summary, these studies suggest that IL-27 inhibits
host defense against M. leprae in infected monocytes.
DISCUSSION
The ability of intracellular pathogens to inhibit host defense
responses contributes to the pathogenesis of human infectious
disease. Here, we explored the role of IL-27 in the immune
response to a microbial pathogen by studying leprosy as a
model. We provide evidence that IL-27 inhibits host defense
in human leprosy as: (i) the induction of the immunosuppres-
sive cytokine IL-10 by both IFN-β and M. leprae was partially
dependent on IL-27, (ii) IL-27 colocalized with IFN-β and
IL-10 in the skin lesions from the progressive L-lep form versus
the self-limited T-lep of leprosy; and (iii) IL-27 suppressed IFN-
γ-induced antimicrobial activity against M. leprae. Together,
these data reveal that the induction of IL-27 provides a
mechanism for suppression of host defense responses in the
pathogenesis of the cutaneous human infectious disease,
leprosy.
Through the analysis of gene expression proﬁles in leprosy,
we identiﬁed IL-27, speciﬁcally the p28 subunit, as an IFN-β
downstream gene associated with the progressive form of the
disease (Waddell et al., 2010; Teles et al., 2013). IL-27 was
part of a common set of 16 IFN-β downstream genes in the
overlap between the gene expression proﬁles derived from
the skin lesions of L-lep patients and the peripheral blood
from two cohorts of patients with active tuberculosis (Berry
et al., 2010; Maertzdorf et al., 2012). Given that M. leprae
induces IFN-β and that IFN-β induces IL-27, M. leprae-
induced IFN-β is a one key event for the induction of IL-27.
Emerging data indicate that mycobacteria induce type I IFN
via cytoplasmic sensors that detect dsDNA and di-cyclic
nucleotides that signal through STING, DDX41, and/or cGAS
(Parvatiyar et al., 2012; Watson et al., 2012; Dey et al., 2015).
It is also possible that M. leprae directly induces IL-27 via a
type I IFN-independent pathway.
Here, we provide evidence that IL-27 has a role in host
defense against M. leprae by inhibiting IFN-γ-induced
antimicrobial activity. In tuberculosis, IL-27 has also been
identiﬁed at the site of disease (Xia et al., 2014) and inhibits
the host defense responses against M. tuberculosis (Robinson
and Nau, 2008). IL-27 has been shown to block IFN-γ-
induced autophagy (Sharma et al., 2014), a key part of the
IFN-γ-induced antimicrobial pathway against M. tuberculosis
(Fabri et al., 2011). Although the present data demonstrate
that IL-27 suppresses IFN-γ-induced antimicrobial activity
against M. leprae, we were unable to experimentally
determine whether IFN-β suppression of this antimicrobial
activity was dependent on IL-27.
Although IL-27 functions as a heterodimer containing p28
and EBI3, EBI3 has been found to be constitutively expressed,
it is suggested that the induction of the p28 subunit is the rate
limiting step in the production of bioactive IL-27 (Remoli
et al., 2007). This is in agreement with our ﬁndings that we
see robust induction in the expression of the p28 subunit and
very little variability in the expression of EBI3.
The present results suggest that one mechanism of IL-10
production in mycobacterial infection involves an M.
leprae→ IFN-β→ IL-27→ IL-10 pathway. We provide evi-
dence that M. leprae induces each of these cytokines, as
well as demonstrate that these cytokines in turn induce the
downstream pathway, i.e., IFN-β induces IL-27 and IL-10, and
IL-27 induces IL-10 directly. Our ﬁnding that IL-27 induces
IL-10 in human monocytes is consistent with a previous study
demonstrating that IL-27 induces IL-10 in mouse bone
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Figure 3. IFN-β induces both IL-27 and IL-10. Total mRNA was isolated from
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(n= 10), T-lep (n=10), and RR (n=10) skin lesions, IL-27p28 and IL-10 mRNA
levels were analyzed by TaqMan quantitative PCR (qPCR). The levels of
IL-27p28 were normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) levels in the same tissue. (f) Correlation between IL-27p28 and IL-10
measured by qPCR. Statistical signiﬁcance was calculated by one-way
ANOVA with Kruskal–Wallis post hoc analysis; **P⩽0.01.
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marrow–derived macrophages (Iyer et al., 2010) and human
T cells (Batten et al., 2008).
The ability of M. leprae and IFN-β to induce IL-10 was
partially dependent on the expression of IL-27. This pathway
is consistent with the ability of LPS to induce type I IFN,
leading to the IL-27-dependent production of IL-10 (Iyer et al.,
2010). IL-10 production in response to Leishmania spp.
infection was also found to be IL-27 dependent (Anderson
et al., 2009). In addition, IL-27 enhanced leishmania growth
in an IL-10-dependent manner (Barreto-de-Souza et al.,
2014). Together, these data support the concept that IL-27
directly induces IL-10 expression.
In some experimental settings, IL-27 suppressed IL-10
production, in particular in the presence of other cytokines
or stimuli. For example, the addition of IL-27 with M-CSF or
monocyte-derived macrophages inhibited TLR-induced IL-10
production (Kalliolias and Ivashkiv, 2008; Zeitvogel et al.,
2012). It is noteworthy that our data demonstrate that in the
skin lesions of leprosy, IL-27 and IL-10 expression correlates,
and the two cytokines colocalize in the progressive form the
disease.
Clearly, microbial pathogens can also induce IL-10 in an
IL-27-independent manner. In our study, the ability of
M. leprae and IFN-β to induce IL-10 was partially blocked
by IL-27 knockdown. The induction of IL-10 by the co-
addition of live M. tuberculosis and IFN-β to mouse bone
marrow-derived macrophages was not inhibited by IL-27 R
deﬁciency. Live M. tuberculosis is known to induce IL-10 via
TLR2 signaling (Jang et al., 2004), a TLR pathway that does
not involve induction of type I IFN. Further studies
demonstrate that engagement of TLRs can directly induce
IL-10 in macrophages (Nair et al., 2009), as can engagement
of CD209 through Raf-1 kinase (Gringhuis et al., 2007).
The role of IL-27 in triggering IL-10 production in
mycobacterial infection suggests that it might be considered
as a therapeutic target. In human cells, type I IFN blocks IL-1
production in response to M. tuberculosis and this blockade
was not reversible by addition of type II IFN (Novikov et al.,
2011). Therefore, neutralization of IL-27 may favor IFN-γ
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responses, which contribute to host defense against myco-
bacterial infection. As IFN-β may also activate immune
responses such as IL-12 induction (Bohnenkamp et al.,
2007), blockade of IL-27 may inhibit the immunosuppressive
pathway induced by IFN-β while preserving its immunosti-
mulatory function. In particular, targeting IL-27 might serve as
a useful adjuvant to traditional antibiotic therapy, perhaps in
the context of multi-drug resistant bacteria.
MATERIALS AND METHODS
Patients and clinical specimens
Patients with leprosy were classiﬁed according to the criteria of
Ridley and Jopling (1966). The designation of tuberculoid leprosy
(T-lep) included patients that were classiﬁed as TT/BT and BT and the
designation of lepromatous leprosy (L-lep) only included patients that
were classiﬁed as LL. All T-lep and L-lep skin biopsy specimens were
taken at the time of diagnosis, before initiating treatment. RR skin
biopsy specimens were considered upgrade reactions; consistent
with reactivation of cell-mediated immune responses against M.
leprae to the tuberculoid pole (usually this reactivation occurs during
treatment, but can also occur spontaneously). Specimens were
embedded in OCT medium (Ames, Elkhart, IN), snap frozen in liquid
nitrogen and stored at − 80 °C. All leprosy patients were recruited
with approval from the Institutional Review Board of University of
Southern California School of Medicine and the Institutional Ethics
Committee of Oswald Cruz Foundation, as well as the University of
California, Los Angeles and gave their written consent.
Whole blood was obtained with informed consent from healthy
donors (UCLA I.R.B. #11-001274), for all samples not involving
leprosy patients. Written consent was received from participants
before inclusion in the study.
Cytokines
The following human recombinant cytokines were used for in vitro
assays, IFN-β (PBL Interferon Source, Piscataway, NJ), IFN-γ
(BD Biosciences, San Diego, CA), IL-10, and IL-27 (R&D Systems,
Minneapolis, MN).
Microarray data analysis
Gene expression proﬁles of mRNAs derived from skin biopsy
specimens of 24 leprosy patients (T-lep, n= 10; L-lep, n= 6; RR,
n= 7) were determined using Affymetrix Human U133 Plus 2.0
microarrays and analyzed as previously described (Teles et al.,
2013). The raw gene expression data analyzed in this study are
available online through the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) accession number GSE17763.
Immunoperoxidase labeling and confocal microscopy
Frozen tissue sections were blocked with normal horse serum before
incubation with mAbs for 60 minutes, followed by incubation with
biotinylated horse anti-mouse IgG for 30minutes and were
visualized using the ABC Elite system (Vector Laboratories, Burlin-
game, CA). Slides were counterstained with hematoxylin and
mounted in crystal mounting medium (Biomeda, Foster City, CA).
Two- and three-color immunoﬂuorescence with confocal micro-
scopy was used to colocalize cytokines with speciﬁc cell markers.
Immunoﬂuorescence was performed by serially incubating cryostat
tissue sections with mouse anti-human mAbs of different isotypes,
anti-CD3 (Clone: UCHT1; IgG1), anti-CD163 (Clone: GH1/61;
IgG1), anti-CD209 (Clone: DCN46; IgG2b), anti-IFN-β (Clone:
MMHB-3; IgG1 or Clone: MMHB-1; IgG2a), anti-IL-10 (Clone:
127107; IgG1 directly conjugated to PE) and anti-IL-27 (Clone:
307426;IgG2a) followed by incubation with isotype-speciﬁc, ﬂuor-
ochrome (A488, A568, or A647)-labeled goat anti-mouse immuno-
globulin antibodies (Molecular Probes, Carlsbad, CA). Controls
included staining with isotype-matched antibodies as described
previously (Ochoa et al., 2008). Nuclei were stained with DAPI (4',6'-
diamidino-2-phenylindole). Double and triple immunoﬂuorescence
of skin sections were examined using a Leica-TCS-SP MP inverted
single confocal laser-scanning and a two-photon laser microscope
(Leica, Heidelberg, Germany) at the Advanced Microscopy/Spectro-
scopy Laboratory Macro-Scale Imaging Laboratory, California
NanoSystems Institute, University of California at Los Angeles.
Bacterial and human cell culture and treatment
M. leprae was grown in the footpad of nu/nu mice, as described
previously (Lahiri et al., 2005) and was provided by Dr James
L Krahenbuhl of National Hansen's Disease Programs, Health
Resources Service Administration, Baton Rouge, LA. Sonicated
M. leprae was provided by Patrick Brennan of the Department of
Microbiology, Immunology & Pathology, Colorado State University,
Fort Collins, CO.
Peripheral blood mononuclear cells were isolated using Ficoll (GE
Healthcare, Piscataway, NJ) gradient centrifugation. Monocytes were
puriﬁed by plastic adherence for 2 hours in RPMI-1640 (Invitrogen)
supplemented with 1% fetal calf serum (Omega Scientiﬁc, Tarzana,
CA). Non-adherent cells were removed via vigorous washing and
cultured in RPMI supplemented with antibiotics and 10% fetal calf
serum. Human adherent monocytes were cultured in RPMI with 10%
fetal calf serum (Omega Scientiﬁc) in the presence or absence of live
M. leprae (MOI 10:1). In a separate set of experiments, monocytes
were stimulated with IFN-β (200 Uml−1), IL-27 (40 ngml−1), or IL-10
(10 ngml−1). After stimulation, the cells were cultured for 3 or
24 hours.
Real-time quantitative PCR
Total RNA was isolated from 10 L-lep, 10 T-lep, and 10 RR skin
lesions, and cDNA was prepared as described previously (Lee et al.,
2010). TaqMan gene expression assays were used for detection of
IFN-β, IL-10, IL-27, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; Applied Biosystems, Foster City, CA). The relative
quantities of the gene tested per sample were calculated against
the GAPDH mRNA using the CT formula as previously described (Liu
et al., 2006).
Antimicrobial assays
To measure type I IFN-induced antimicrobial activity in M. leprae-
infected macrophages, we adapted the previously described real-
time PCR-based method for the assessment of bacterial viability,
which compares 16S RNA levels with genomic DNA levels (Martinez
et al., 2009; Liu et al., 2012). Monocytes were isolated as described
above, pretreated with IFN-γ (273 Uml−1) for 24 hours and infected
overnight with M. leprae at an MOI of 10:1 followed by stimulation
with IFN-β (200 Uml− 1), IFN-γ, IL-10 (10 ngml− 1), IL-27 (40
ngml− 1) or medium for 3 days. Total RNA and DNA were isolated
as previously described (Liu et al., 2012). Brieﬂy, cDNA was
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synthesized from the total RNA as described (Liu et al., 2006) for both
human and bacterial mRNAs. The bacterial 16S rRNA and genomic
element DNA (RLEP (M. leprae speciﬁc repetitive element)) levels
were then assessed using real-time PCR. To normalize for the total
monocytes present in the culture, 36B4 was also evaluated.
Comparison of the bacterial DNA with the mammalian 36B4 levels
was used to monitor infectivity between all the conditions in the
assay as well as PCR quality. The 16 S rRNA and genomic DNA
values were calculated using the ΔΔCT analysis, with the bacterial
DNA value serving as the housekeeping gene. The M. leprae 16 S
rRNA and M. leprae repetitive genomic element (RLEP) primers used
were as previously described (Martinez et al., 2009; Liu et al., 2012).
ELISA
Secreted IFN-β, IL-10, and IL-27 proteins in the supernatant were
measured using VeriKine Human Interferon-Beta ELISA Kit (PBL
Interferon Source), IL-10 (Invitrogen), IL-27 Duoset ELISA (R&D
Systems) following the manufacturer protocols.
Primary cell siRNA transfection
siRNA transfection into primary human peripheral blood mono-
nuclear cells was accomplished using the Amaxa Nucleofection
System and the Human Monocyte Kit (Lonza, Walkersville, MD)
according to the manufacturer’s recommendations. ON-TARGET
plus SMARTpool; siIL27 siRNA constructs were used at 100 pmol per
transfection. Transfection efﬁciency of siRNA into primary mono-
cytes was assessed using siGLO, a ﬂuorescently labeled control oligo
(Dharmacon, Lafayette, CO). Cells were allowed to rest for 18 hours
following transfection before stimulation. At the time of stimulation,
non-adherent cells were removed and fresh media was added.
Statistical analysis
Results are reported as pooled data from an entire series of
experiments, and described as mean± the SEM unless otherwise
indicated. For data comparison, the Student’s t-test was used with
statistical signiﬁcance at Po0.05.
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